Skip to main content

Health Canada has suspended the licence of a Mississauga manufacturer of hand sanitizer and issued an expanded recall for some of its products found to contain unauthorized ingredients that could be unsafe for consumers.

The government agency said Thursday that Bio Life Science Corp.'s Daily Shield-branded hand sanitizer is being pulled off the shelves of Dollarama Inc. and any other unspecified retailers across the country it may have been sold at.

The 250 mL product was found to contain less than the recommended amount of ethanol, which decreases the chances of the product being effective at killing bacteria and viruses. The sanitizer also contained methanol, which poses serious health risks because it can cause severe adverse reactions or death when ingested.

Story continues below advertisement

“Health Canada also identified that Bio Life had a number of good manufacturing practices violations, including poor record-keeping, lack of control of inventory, and lack of finished product testing,” the agency said in a release.

“As a result, Health Canada directed the company to stop all licensable activities. All product licences held by the firm have been suspended and an intent to revoke the COVID-19 site licence has been issued.”

Bio Life did not immediately response to a request for comment.

The enhanced restrictions against the company come after its sanitizer was first recalled last week.

At the time, Health Canada said it believed the products, labelled NPN 80098979, Lot 6942 Expiry May 2023, were counterfeit.

The agency said it has now determined the items are not counterfeit, but that it is continuing to investigate Bio Life’s other products – wipes, gels and liquid-based sanitizers – to determine if other action is needed.

When asked whether the agency will be fining or charging Bio Life, Health Canada said in a statement that it is “committed to stopping the production and import of unauthorized or counterfeit drugs in Canada and will not hesitate to take additional actions as necessary to stop this illegal activity.”

Story continues below advertisement

Since the COVID-19 pandemic began and dozens of distillers and new companies began pumping out hand sanitizer, Health Canada said it has had to recall more than 100 of the products it found concerning.

Montreal-based Dollarama, where Bio Life’s problematic hand sanitizer was first found by Health Canada in Thunder Bay, Ont., previously said that the product was available in roughly half the chain’s stores and each location sold about 17 bottles.

Dollarama said the sanitizers were removed as soon as Health Canada began investigating and the agency is now working to verify that it is no longer being sold by any other distributors or retailers.

Anyone who purchased this product, Health Canada said to stop using it immediately.

With files from Adam Burns.

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies